Average Co-Inventor Count = 4.01
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Millennium Pharmaceuticals Limited (8 from 850 patents)
2. Eisai R&d Management Co., Ltd. (7 from 529 patents)
3. Dana-farber-cancer Institute Inc. (2 from 1,210 patents)
4. Takeda Pharmaceutical Company Limited (2 from 1,179 patents)
19 patents:
1. 12391671 - Allosteric EGFR inhibitors and methods of use thereof
2. 12377080 - Allosteric EGFR inhibitors and methods of use thereof
3. 12054512 - Sting modulator compounds, and methods of making and using
4. 11542293 - Sting modulator compounds, and methods of making and using
5. 10538533 - Heteroaryls and uses thereof
6. RE47797 - Intermediates for the preparation of analogs of halichondrin B
7. 10450324 - Methods useful in the synthesis of halichondrin B analogs
8. 10202373 - Heteroaryls and uses thereof
9. 10144742 - Quinoxaline compounds and uses thereof
10. 10030032 - Methods useful in the synthesis of halichondrin B analogs
11. 9802960 - Heteroaryls and uses thereof
12. 9751854 - Heteroaryls and uses thereof
13. 9695188 - Methods useful in the synthesis of halichondrin B analogs
14. 9469651 - Halichondrin B analogs
15. 9206194 - Halichondrin B analogs